- Home
- FSHP vs AVTX Comparison
FSHP vs AVTX Comparison
Compare FSHP & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSHP
- AVTX
- Stock Information
- Founded
- FSHP 2018
- AVTX 2011
- Country
- FSHP United States
- AVTX United States
- Employees
- FSHP N/A
- AVTX N/A
- Industry
- FSHP
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- FSHP
- AVTX Health Care
- Exchange
- FSHP NYSE
- AVTX Nasdaq
- Market Cap
- FSHP 92.2M
- AVTX 57.4M
- IPO Year
- FSHP 2024
- AVTX 2015
- Fundamental
- Price
- FSHP N/A
- AVTX $5.09
- Analyst Decision
- FSHP
- AVTX Strong Buy
- Analyst Count
- FSHP 0
- AVTX 7
- Target Price
- FSHP N/A
- AVTX $31.00
- AVG Volume (30 Days)
- FSHP 754.0
- AVTX 122.3K
- Earning Date
- FSHP 01-01-0001
- AVTX 08-11-2025
- Dividend Yield
- FSHP N/A
- AVTX N/A
- EPS Growth
- FSHP N/A
- AVTX N/A
- EPS
- FSHP 0.21
- AVTX N/A
- Revenue
- FSHP N/A
- AVTX $441,000.00
- Revenue This Year
- FSHP N/A
- AVTX N/A
- Revenue Next Year
- FSHP N/A
- AVTX N/A
- P/E Ratio
- FSHP $49.03
- AVTX $0.74
- Revenue Growth
- FSHP N/A
- AVTX N/A
- 52 Week Low
- FSHP $9.99
- AVTX $3.39
- 52 Week High
- FSHP $10.48
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- FSHP N/A
- AVTX 57.49
- Support Level
- FSHP N/A
- AVTX $4.76
- Resistance Level
- FSHP N/A
- AVTX $5.05
- Average True Range (ATR)
- FSHP 0.00
- AVTX 0.30
- MACD
- FSHP 0.00
- AVTX 0.03
- Stochastic Oscillator
- FSHP 0.00
- AVTX 84.75
About FSHP FLAG SHIP ACQUISITION CORPORATION
Flag Ship Acquisition Corp is a blank check company formed to effect a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).